• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤出血类型作为预测儿童慢性免疫性血小板减少症的支持因素

Cutaneous Hemorrhage Types as Supportive Factors for Predicting Chronic Immune Thrombocytopenia in Children.

作者信息

Kalfon Sarit, Hamadeh Haitham, Schachter Yaakov, Sharon Nechama

机构信息

Department of Pediatrics.

Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

出版信息

J Pediatr Hematol Oncol. 2018 Jul;40(5):337-340. doi: 10.1097/MPH.0000000000001167.

DOI:10.1097/MPH.0000000000001167
PMID:29668541
Abstract

Our objective was to assess risk factors for developing chronic immune thrombocytopenia (ITP) in children. The charts of all consecutive children diagnosed with ITP between 2000 and 2015 at a single center were retrospectively reviewed, and clinical characteristics at initial presentation were analyzed. Sixty-two children were included in the study (mean age, 6.15 y); 44 (71%) were found to have acute ITP, and 18 (29%) developed chronic ITP (permanent or relapsing thrombocytopenia >12 mo). In a univariate analysis, cutaneous hemorrhages were observed significantly more in acute patients (90.9%) than in chronic patients (61.1%). Patients who had acute ITP were more likely to present with a combination of petechiae, purpura, and/or ecchymosis (75%) than patients with chronic disease (44.4%, P=0.010). In multivariate analysis, older age increased the risk (odds ratio=1.1; P<0.05) for chronic disease, and manifestations of combination skin hemorrhages (petechiae/purpura/ecchymosis) reduced the risk (odds ratio=0.167; P<0.05). In conclusion, the most important risk factor for chronic disease is older age. Skin hemorrhage types were found to be a supportive factor for the prediction process: the combination of petechia/purpura/ecchymosis was associated with a lower risk for developing chronic disease compared with petechiae alone. Future studies should assess the prognostic value of skin hemorrhage types that are a simple way to predict the course of ITP in children.

摘要

我们的目标是评估儿童慢性免疫性血小板减少症(ITP)的发病风险因素。对2000年至2015年在单中心确诊为ITP的所有连续儿童的病历进行回顾性审查,并分析初次就诊时的临床特征。62名儿童纳入研究(平均年龄6.15岁);44名(71%)为急性ITP,18名(29%)发展为慢性ITP(持续性或复发性血小板减少症>12个月)。单因素分析显示,急性患者(90.9%)出现皮肤出血的情况显著多于慢性患者(61.1%)。急性ITP患者比慢性病患者更易出现瘀点、紫癜和/或瘀斑(75%对44.4%,P=0.010)。多因素分析显示,年龄较大增加了患慢性病的风险(比值比=1.1;P<0.05),而合并皮肤出血(瘀点/紫癜/瘀斑)表现降低了风险(比值比=0.167;P<0.05)。总之,慢性病最重要的风险因素是年龄较大。发现皮肤出血类型是预测过程中的一个支持因素:与单纯瘀点相比,瘀点/紫癜/瘀斑合并出现与患慢性病的风险较低有关。未来的研究应评估皮肤出血类型的预后价值,这是预测儿童ITP病程的一种简单方法。

相似文献

1
Cutaneous Hemorrhage Types as Supportive Factors for Predicting Chronic Immune Thrombocytopenia in Children.皮肤出血类型作为预测儿童慢性免疫性血小板减少症的支持因素
J Pediatr Hematol Oncol. 2018 Jul;40(5):337-340. doi: 10.1097/MPH.0000000000001167.
2
Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.北欧国家儿童特发性血小板减少性紫癜:慢性病的流行病学及预测因素
Acta Paediatr. 2005 Feb;94(2):178-84. doi: 10.1111/j.1651-2227.2005.tb01887.x.
3
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.特发性血小板减少性紫癜:阿拉巴马儿童医院的一项为期10年的自然史研究。
Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802.
4
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.儿童和青少年免疫性血小板减少症的隐匿性出血:与实验室参数和健康相关生活质量的关系。
J Thromb Thrombolysis. 2020 Aug;50(2):258-266. doi: 10.1007/s11239-020-02036-4.
5
Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.儿童免疫性血小板减少症缓解的预测因素:来自泰国一家三级中心的经验。
Pediatr Blood Cancer. 2017 Jan;64(1):128-134. doi: 10.1002/pbc.26178. Epub 2016 Aug 30.
6
Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.年龄和出血症状持续时间可最佳预测儿童免疫性血小板减少症在 3、6 和 12 个月时的缓解情况。
J Pediatr. 2013 Nov;163(5):1335-9.e1-2. doi: 10.1016/j.jpeds.2013.06.018. Epub 2013 Jul 25.
7
A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.一项基于人群的多中心队列研究,旨在探究儿童慢性特发性血小板减少性紫癜的预测因素。
Pediatrics. 2008 Mar;121(3):e506-12. doi: 10.1542/peds.2007-1129.
8
Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.中国免疫性血小板减少症儿童的严重出血
J Pediatr Hematol Oncol. 2015 Apr;37(3):e158-61. doi: 10.1097/MPH.0000000000000292.
9
Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.原发性免疫性血小板减少症中的危及生命的出血事件:一项对169例住院患者的单中心回顾性研究。
Ann Hematol. 2017 Nov;96(11):1915-1920. doi: 10.1007/s00277-017-3095-6. Epub 2017 Aug 14.
10
The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States.美国儿科患者免疫性血小板减少症的发病率和临床负担。
Platelets. 2020;31(3):307-314. doi: 10.1080/09537104.2019.1635687. Epub 2019 Jul 4.

引用本文的文献

1
Low molecular weight heparin dosing regimens after total joint arthroplasty: a prospective, single-center, randomized, double-blind study.全膝关节置换术后低分子肝素给药方案:一项前瞻性、单中心、随机、双盲研究。
J Orthop Surg Res. 2024 Nov 27;19(1):799. doi: 10.1186/s13018-024-05303-9.
2
The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty.抗Xa因子活性在全膝关节置换术后接受利伐沙班治疗的患者瘀斑管理中的作用
J Clin Med. 2023 Feb 1;12(3):1161. doi: 10.3390/jcm12031161.
3
Risk Factors and Psychological Analysis of Chronic Immune Thrombocytopenia in Children.
儿童慢性免疫性血小板减少症的危险因素及心理分析
Int J Gen Med. 2020 Dec 30;13:1675-1683. doi: 10.2147/IJGM.S290459. eCollection 2020.